HIG1 hypoxia inducible domain family member 1A pseudogene 13 (HIGD1AP13)

HIGD1AP13 is annotated as a human processed pseudogene located in the genome, with high sequence similarity to its parental gene HIG1 hypoxia inducible domain family member 1A (HIGD1A)[3][5][7]. Pseudogenes such as HIGD1AP13 do not produce functional proteins due to disabling mutations, but in some cases, their RNA transcripts may influence cellular processes indirectly—mainly by acting as miRNA decoys or ceRNAs that impact gene regulation[2][8][9]. However, there is currently no functional or disease association published for HIGD1AP13 specifically, and no evidence for its use as a therapeutic, diagnostic, or prognostic target in any disease[3][5][7]. Pseudogenes as a category have been recognized for roles in gene regulation (e.g., acting as miRNA sponges to regulate parental gene expression in cancer or other diseases), but these functions are established for only a subset of pseudogenes and not for HIGD1AP13 in particular[2][6][8][9]. The entry is not a receptor, enzyme, transporter, or typical molecular drug target. There are no interacting drugs, mechanisms of action, biomarker data, or specific biological/disease roles available for HIGD1AP13. It should be classified as a pseudogene and not considered as a primary molecular target for drug development or clinical monitoring.

Other names

HIGD1AP13